<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://ccforum.com/feeds/articlecomments?arxId=cc6135&amp;format=rss&amp;version=&amp;quantity=">
        <title>Article Comments - 'Albumin and furosemide for acute lung injury'</title>
        <link>http://ccforum.com/content/11/5/314/comments</link>
        <description>The latest comments on the article 'Albumin and furosemide for acute lung injury'</description>
        <dc:date>2007-10-08T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li resource="http://ccforum.com/content/11/5/314" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://ccforum.com/content/11/5/314/comments#285652">
        <title>Will albumin provide any benefit in a severely ill group?</title>
        <link>http://ccforum.com/content/11/5/314/comments#285652</link>
        <description>&lt;p&gt;I think that the median Apache score of the study population was about 15. In a population with a greater severity of illness we might expect the level of inflammation and therefore endothelial dysfunction to be greater. It is possible that if that were the case the albumin may leak out of the vascular compartment and not provide the same increase in oncotic pressure. The benefits of such a therapy may then be lost. However the concept of increasing oncotic pressure and simultaneous diuresis for ALI/ARDS is certainly appealing.&lt;/p&gt;</description>
                <dc:creator>Shahed Omar</dc:creator>
                <dc:date>2007-10-08T00:00:00Z</dc:date>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
